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Abstract 
Background: Beta-sitosterol (BS) is a compound discovered to be present in numerous plants. A number of interesting 
biomedical properties have been attributed to BS, including immuno-modulating and anti-inflammatory activities. 
Therefore, the aim of this report was to evaluate its anti-inflammatory capacity by applying various rodent 
experimental tests. 
Methods. To carry out the objective of the study we applied the methods indicated here. Two of the adopted methods 
were based on the passive reverse Arthus reaction: the rat paw edema test and the rat pleurisy assay. We also applied 
two methods related with the non-specific acute inflammation: the mouse ear edema test, and the mouse 
mieloperoxidase activity assay.  
Results. The results obtained in all tests established a significant anti-inflammatory potential of BS. In the rat paw 
edema test we found an inhibitory effect which goes from 50-70%; in the rat pleurisy assay our findings with respect to 
the volume of pleural exuded showed a reduction of 46%, as well as a 20% low amount of neutrophils in comparison 
with the level of the control group.  In the mouse ear edema test we found a mean inflammatory inhibition of 75%, and 
with respect to mieloproxidase activity the results showed a significant inhibition induced by the three doses of BS. 
Conclusions. In the present study we determined a potent anti-inflammatory capacity of BS in specific and non-
specific types of acute inflammation in rodents.  
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Introduction 
 
Inflammation is a relevant physiological event which is needed for the maintenance of tissue homeostasis; it 
is a reaction of an organism to cell and tissue damage caused by a variety of agents, as well as to autoimmune events 
(Perez et al., 2014). During this process, microcirculatory events occur, including vascular permeability, changes in the 
movement, recruitment and accumulation of leukocytes, besides the release of inflammatory mediators (Medzhitov, 
2010). Resolution is necessary to restore the original morphology and function of the affected tissue. This is an active 
process coordinated by a number of intracellular and extracellular molecules. In the process, a reduction of 
proinflammatory mediators occur, in addition to the release of pro-resolving mediators which prevents migration of 
leukocytes and increases their apoptosis (Serhan and Savill, 2005; Serhan et al., 2007). These events start the resolution 
process and are required to restore tissue homeostasis. When inflammation is unresolved, or excessive initial 
inflammation is produced, a variety of chronic inflammatory diseases can be developed affecting a number of organs; 
for example, organs that may be affected are those which belong to the respiratory and digestive systems. Likewise, 
inflammatory diseases developed can also originate rheumatoid arthritis, a systemic, autoimmune disease characterized 
by chronic inflammation mainly affecting the joints, where it can produce a progressive degree of deformity and 
functional disability related with progressive cartilage destruction, as well as with damage in tendons, ligaments and 
bones. Moreover, the disease can affect other organs, such as eyes, lungs, pleura, heart, skin, and blood vessels 
(McIlness and Schett, 2011; Gaffo et al., 2006). 
Pharmacologic treatments are mainly designed to resolve, deter or improve the quality of life affected by 
inflammatory diseases. A number of drugs have been designed and applied depending on the affected organ, the status 
of the disease and the characteristics of the involved patient; however, the therapy can be expensive, and its effect may 
be symptomatic, non-permanent, and could cause collateral damage. For example, non-steroidal anti-inflammatory 
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drugs can have adverse effects on bone tissue by modulating the proliferation, differentiation, adhesion, and migration 
of osteoblasts (Garcia-Martinez et al., 2015); some of the mentioned drugs, as well as aspirin, have been associated 
with upper gastrointestinal tract injury, including bleeding and ulcers (Goldstein, 2004; Goldstein and Crier, 2015), and 
they confer an increased risk for thrombotic and congestive heart failure (Farkouh et al., 2007). Furthermore, another 
risk factor to be considered is the concurrent use of anti-inflammatory drugs with other medications such as 
anticoagulants, corticosteroids, serotonin reuptake inhibitors or antihypertensive agents (Goldstein and Cryer, 2015; 
Kalafutova et al., 2014). This complexity makes the search for new compounds worthwhile, with efficacy both to 
reduce the pathophysiological mechanisms leading to the disease, and to lessen few if any, toxic side effects. Plant 
extracts or plant-derived compounds are under investigation in order to accomplish these purposes. In these efforts, a 
number of screening tests can be used in rodents, including the immune complex-induced reversed passive Arthus 
reaction (Bailey and Sturm, 1983; Szalai et al., 2000).  
Beta-sitosterol (BS) is a vegetable-derived compound found in plants such as rice, wheat, corn, nut, peanut, 
and particularly in cat’s claw (Uncaria tomentosa), where it has been suggested to be involved in the curative 
properties attributed to the plant on inflammation, viral damage, ulcer, cancer development, as well as in the 
enhancement of the immune system (Heitzman et al., 2005; Ling and Jones, 1995). BS is a chemical structurally related 
to cholesterol, but more slowly absorbed into the intestinal tract, interfering with the cholesterol absorption and 
preventing its rise in serum (Tapiero et al., 2003). Besides, BS is suggested to modulate the immune function, 
inflammation, and pain levels by controlling the production of inflammatory cytokines (Awad and Fink, 2000). Based 
on the abovementioned information, we extended studies in the present report on the capacity of BS as an anti-
inflammatory agent by applying various tests in rodents. 
 
 
Material and methods 
Chemicals and animals 
 
BS, ibuprofen, prednisone, chicken egg albumin, indomethacin, 12-O-tetradecanoylphorbol-13-acetate 
(TPA), tetramethyl benzidine (TMB), hexadecyltrimethyl ammonium bromide, acetone, sodium acetate, hydrogen 
peroxide, as well as ethylic ether and NaCl were purchased from Sigma Chemicals (St. Louis, MO, USA). Ovalbumin 
antiserum (rabbit polyclonal to ovalbumin) was obtained from Abcam (Mexico City).  
For the assay, we used eight-week-old male Wistar rats with a mean weight of 250 g and mouse (CD1) with 
a mean weight of 25 g. The animals were obtained from the National Institute of Rehabilitation and maintained in 
metallic cages, at 23º C, in a 12 h dark-light cycle, and permitted to freely consume food (Rodent Lab Chow 5001, 
Purina) and water. The experimental procedure was approved by the Committee of Ethics and Biosecurity of the 
National Rehabilitation Institute.  
 
Inductions of rat paw edema  
 
For this assay, we followed the reverse passive Arthus reaction (Pflum and Graeme, 1979) with some 
modifications. Initially, the substance corresponding to each experimental group was administered, followed by the 
induction of the antigen-antibody reaction to each rat. We used 30 rats organized in 6 groups with 5 individuals each: a 
negative control group that was intra-gastrically (IG) administered with mineral oil; three other groups that were IG 
administered with BS (50, 100 and 200 mg/kg), previously diluted in mineral oil; and finally, two more groups 
intraperitoneally (IP) administered with known anti-inflammatory drugs, in which one group was injected 200 mg/kg of 
ibuprofen (a non-steroidal anti-inflammatory agent), and the other group was injected with 10 mg/kg of prednisone (a 
steroidal anti-inflammatory agent).  All animals were immediately injected with 0.1 ml of anti-ovalbumin antibody 
(diluted 1:3) in the hindquarter of the plantar area of the right leg, and in the contralateral leg; rats were injected with 
0.1 ml of 0.9 % NaCl. In a subsequent step, all animals were intravenously (IV) injected with a suspension of egg 
albumin (25 mg/kg).  
The volume of the swollen leg was determined with a digital pletysmometer 3 h after the ovoalbumin 
injection. The paw edema value was established by determining the difference between the volume obtained in the 
treated leg and in the control (left leg). For data calculation, the volume of the swollen leg was considered to represent 
100% inflammation.  
 
Pleurisy assay in rats 
 
This assay was also based on the reverse passive Arthus reaction (Pflum and Graeme, 1979) with some modifications. 
In the first instance, we injected 0.2 ml anti-ovalbumin antibody (diluted 1:10) to the pleural cavity of rats in order to 
induce the immunocomplex; 20 min later all animals were IV injected with 25 mg/kg of ovalbumin. Six groups with 5 
rats each were used for the experiment. Two positive control groups were included in the study: one IP administered 
ibuprofen (200 mg/kg), and another IP injected 10 mg/kg of prednisone; besides these groups, three more groups were 
IG treated with BS diluted in mineral oil (50, 100, and 200 mg/kg, respectively); finally, we included a negative control 
group IG administered with mineral oil. Six hours after the pleural inoculation, rats were sacrificed by cervical 
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dislocation; then, the exuded volume of the pleural cavity was quantified and centrifuged at 3000g for 5 min. The 
sediment was placed on a slide, fixed with methanol and stained with Giemsa for 10 min. Then, a differential counting 
of neutrophiles and lymphocytes was made.  
 
Mouse ear edema assay  
 
For this test, we followed the guidelines described by Young and De Joung (1989) to measure inflammation 
using TPA. All substances were dissolved in acetone. Five groups with five individuals each were topically 
administered with TPA (2.5 µg) as phlogistic agent, in both the internal and external surface of the right ear of each 
mouse. Also, 20 µl of acetone were applied to the left ear of each mouse. One hour later, BS (0.5, 1.0 and 1.5 mg) was 
topically applied to the right ear of the individuals of three groups. Besides, we also included a group administered 
indomethacin (0.5 mg/ear) as positive control. Four hours after the chemical administration, mice were cervically 
dislocated, and a section (7mm diameter) of the central portion of both ears was obtained and weighed. 
The value of the edema was calculated by the difference between the weight of the treated right ear and the 
non-treated left ear. The inhibitory effect of the edema (in percentage) was calculated in comparison with the edema 
detected in the TPA treated group.  
 
Inhibition of mieloperoxidase (MPO) activity   
 
For this assay, we followed the method described by Suzuki et al. (1983) modified by Young and De Joung 
(1989) for use in a plate reader. MPO activity was measured from the ears of mice treated with TPA, BS, and 
indomethacin. These ears belonged to individuals from the previously described mouse ear edema assay. They had 
been weighted and kept frozen at - 20 °C until use. At this time, ears were homogenized and centrifuged at 11 200g at 4 
°C for 20 min. After that, 30 μl of the supernatant were added to the reaction mixture which consisted of phosphate 
buffer (50 mmol/l, pH 5.4), TMB (1.6 mmol/l), 0.5% hexadecyltrimethyl ammonium bromide, and H2O2 (1 mmol/l). 
The reaction was carried out for 3 min at 37 °C and then it was stopped by adding sodium acetate 1.46 M. Absorbances 
of the samples were read at 630 nm. The enzyme inhibition (expressed in percentage) corresponded to the absorbance 
difference between the treated groups with respect to the TPA treated group.  
 
Statistics 
 
The statistical analysis of data obtained from the different anti-inflammatory assays was performed with an 
ANOVA followed by the Student t test. For this purpose, we used the SPSS 11.0.1 computer program (Statistical 
software, Inc., Chicago, IL, USA).  
 
 
Results 
 
The results obtained in the rat paw edema test are shown in Figure 1. The three tested doses of BS were 
found to induce a significant, dose dependent inhibition of the edema in comparison with the result found in the control 
group. The inhibition was 51, 63, and 70% with 50, 100, and 200 mg/kg of BS, respectively. Interestingly, the high 
dose of BS was 17% more effective than ibuprofen and 11% more effective than prednisone. 
In the pleurisy assay, the effect of BS on the exudative pleural effusion induced with the antigen/antibody 
reaction corresponded to 2.1, 1.8, and 2.2 ml with the low, intermediate and high tested doses (Figure 2). This result 
represents a mean reduction of 46% with respect to the amount of the control (3.8 ml), and a higher reduction with 
respect to the level induced by ibuprofen (31%) and prednisone (36%). 
In regard to the amount of neutrophils and lymphocytes determined in the pleural cavity of rats, the results 
are presented in Figure 3. In this study, the percentage of neutrophils induced by BS corresponded to 60, 57 and 59 % 
with 50, 100, and 200 mg/kg of the chemical, respectively (Figure 3A); these values were about 20% lower than those 
observed in the negative group, as well as more than 6% of the observed values in the prednisone and ibuprofen treated 
mice. In regard to lymphocytes, results determined with BS after the antigen/antibody reaction showed a duplication of 
the value obtained in the negative control group, and only about 4% lower than the one observed in rats administered 
ibuprofen or prednisone (Figure 3B). 
Table 1 shows results concerning the mouse auricular edema test. In this assay we determined a dose-
dependent inhibition induced by BS, with a mean effect of 75%, which is slightly higher than the effect produced by 
indomethacin; however, with 1.5 mg/ear of BS the difference reached 14%. 
Finally, in regard to the myeloperoxidase assay, we found a significant inhibitory effect produced with the 
tested doses of BS, the high dose of BS (1.5 mg/ear) being slightly better than the inhibition observed with 
indomethacin (Table 2).  
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Figure 1: Anti-inflammatory effect of beta-sitosterol (BS) in the rat paw edema test 
IBU = Ibuprofen; PRE = Prednisone. Each bar represents the mean ± SEM of five animals per group. *Statistically 
significant difference with respect to the result of mineral oil; ANOVA and Student t tests, p ≤ 0.05 
 
 
Figure 2: Anti-inflammatory effect of beta-sitosterol (BS); Determination of rat pleural effusion 
IBU = Ibuprofen; PRE = Prednisone. Each bar represents the mean ± SEM of five animals per group. *Statistically 
significant difference with respect to the result of mineral oil; ANOVA and the Student t tests, p≤0.05 
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Figure 3: Quantification of neutrophils (A) and lymphocytes (B) observed in the rat pleurisy assay 
IBU = Ibuprofen; PRE = Prednisone. Each bar represents the mean ± SEM of five animals per group. *Statistically 
significant difference with respect to the result obtained for mineral oil; ANOVA and Student t tests, p≤0.05 
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Table 1: Anti-inflammatory effect of beta-sitosterol (BS) in the mouse ear edema test 
 
Treatment              Dose (mg/ear)             Edema (mg)                Inhibition % 
         TPA             0.0025         19.70.60   -- 
         IND                  0.5                  5.90.72  70.3* 
         BS    0.5      6.70.69  66.0* 
         BS       1.0      5.41.5  74.2* 
         BS  1.5       3.10.93   84.1* 
IND=indomethacin. The obtained results represent the mean  EEM of 5 mice per group. *Statistically significant 
difference with respect to 12-O-tetradecanoylphorbol-13-acetate (TPA) treated animals. ANOVA and Student t tests, 
p≤0.05 
 
Table 2:Anti-inflammatory effect of beta-sitosterol (BS); Determination of mieloperoxidase activity 
 
         Treatment                       Dose (mg/ear)                  Inhibition % 
        TPA                        0.0025      -- 
        IND                0.5                   95.36* 
 
         BS                 0.5              56.39* 
         BS              1.0                79.20* 
         BS              1.5   98.90*        
IND=indomethacin. The inhibiton percentage was calculated according to the equation %I=DAc-DAp x 100/DAc; 
where DAc is the arithmetic mean of the control absorbance, and DAp the arithmetic mean of the tested agent 
absorbance. The obtained results represent the mean  EEM of 5 mice per group. *Statistically significant difference 
with respect to the value obtained in 12-O-tetradecanoylphorbol-13-acetate (TPA) treated animals; ANOVA and 
Student t tests, p≤0.05 
 
Discussion 
Inflammation is a process that can represent a prelude for the development of the final disease, which is the 
case of a chronic inflammatory state in the digestive apparatus that may conclude with gastrointestinal cancer (Susuki 
et al., 2005); however, it could also correspond to the main clinical symptom that characterizes a number of well-
established pathologies, for example, the systemic inflammatory response syndrome (Fry, 2012). Therefore, due to its 
high public health relevance, investigations are constantly in progress to find new drugs with better characteristics than 
those on the market. In these efforts, the identification of plants with anti-inflammatory properties has produced 
valuable knowledge. Plant species with this property have been found in a variety of families, including Rubiaceae, 
Moraceae, Gentianaceae, Compositae, Myrtaceae, Arecaceae, and Boraginaceae, among others (He et al., 2014; Huang 
et al., 2013; Jamkhande et al., 2013; Dwevedi et al., 2015; Uddin et al., 2014; Anyanwu et al., 2015; Piscoya et al., 
2001; Naressi et al., 2012). Authors in this research field have generally proposed that medicinal effects of plant 
extracts were due to synergism among the identified compounds, which include flavonoids, tannins, acethophenone 
derivatives, and sterols, among others. Moreover, due to this variety of useful chemicals, medicinal plants may usually 
act on various diseases, complicating then the correlation of a compound´s effect with a specific illness. Therefore, 
another route of investigation is the determination of pharmacological effects induced by specific compounds. 
Phytosterols are plant derived steroid alcohols that are part of the cell membrane and they have structural 
resemblance to cholesterol, which enables them to displace low density lipoprotein cholesterol in the intestine 
(Choudary and Trans, 2011). Three phytosterols predominate in the human herbal nutrition: BS, campesterol, and 
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stigmasterol (Saeidnia et al., 2014).  
In the present report, we evaluated the effect of BS by using two types of acute inflammatory reactions, one 
of them corresponded to an immune reaction (reversed passive Arthus reaction in the rat) and the other to a non-
specific reaction (mouse ear edema assay). Our results showed that BS had a prominent anti-inflammatory potential in 
both types of inflammation. In regard to the Arthus reaction, BS inhibited the rat paw edema induced by the reaction 
antigen/antibody from 50-70%. Moreover, the compound also decreased 46% the volume of the pleural fluid induced 
by the same reaction; besides, an increase of neutrophils by BS was also observed in the same assay.  These results are 
concordant with both the inhibition of edema and the infiltration of inflammatory cells.  
The reversed passive Arthus reaction is an immunologically induced inflammatory response characterized by 
immune complex deposition, complement fixation, polymorphonuclear leukocyte infiltration and tissue damage (Pflum 
and Graeme, 1979).  The anti-inflammatory activity of BS inhibited the reversed passive Arthus reaction  probably 
because of the inhibition of the mediators that give rise to the full Arthurs lesion; in this sense, other authors have 
provoked ovoalbumin-induced asthmatic mice, and found that BS mitigated the inflammation by eosinophil infiltration 
and mucus hypersecretion by goblet hyperplasia, and that various inflammatory biomarkers also decreased in the lung 
tissue and brochoalveolar lavage fluid (Yuk et al., 2007; Han et al., 2014; Liz et al., 2013; Mahajan and Metha, 2011; 
Loizou et al., 2010). 
Furthermore, our results also showed that BS diminished the edema produced by TPA, as well as the 
mieloperoxidase activity, results which were related to a non-specific inflammatory reaction. In this respect, studies 
regarding the anti-inflammatory effect of BS have been published since the early 80s, where authors showed such an 
effect employing carrageenan-induced edema, cotton pellet implantation and Brewer`s yeast induced pyrexia in rats 
(Gupta et al., 1980). From that time onward a number of anti-inflammatory, antypiretic, antinociceptive, and 
immunomodulating activities have also been reported (Bouic, 2002; Saeidnia et al., 2014). 
However, in vitro and in vivo experimental studies on the BS anti-inflammatory potential had been limited 
until recently, and they are now being increasingly advanced by the relevance that is being demonstrated for the studied 
compound. This type of research has shown a number of actions produced by BS: it was able to inhibit both vascular 
adhesion and intracellular adhesion molecule 1 expression in TNF-alpha-stimulated human aortic endothelial cells; in 
2,4-dinitrofluorobenzene-induced mouse dermatitis, it was able to significantly reduce the clinical severity by 
inhibiting the infiltration of inflammatory cells, and the levels of IgE, interleukin-4, and histamine in the serum of 
treated mice; also, in the mouse carrageenan-induced inflammation air pouch model, it was determined that the 
chemical promoted a time- and dose-dependent increase of the calcium uptake in activated neutrophils, and inhibited 
myeloperoxidase, adenosine deaminase, interleukin-1 and the tumor necrosis factor. The mentioned effects, as well as 
the findings of the present report, support the suggested beneficial effects of BS for a number of diseases, which 
include benign prostatic hyperplasia, colon and breast cancer, atherosclerosis, and gastrointestinal ulceration (Wilt et 
al., 1999; Choudary and Trans, 2011; Hewing and Fisher, 2012; Tovey, 2015).  
 
Conclusion 
 
The present study demonstrated the prominent anti-inflammatory potential of BS in two types of acute 
inflammatory reactions: one was an immune reaction expressed by the reversed passive Arthus reaction in the rat, and 
the other was a non-specific reaction shown in the mouse ear edema assay. Its effect was at least similar to the selected 
reference anti-inflammatory compounds. 
 
 
Acknowledgments 
 
 The authors wish to thank Dr. Rebeca E. Franco y Bourland, Head of the Biochemistry Service, for her 
support. 
 
 
References 
 
1. Anyanwu GO, Ur-Rehman N, Onyeneke CE and Rauf K (2015) Medicinal plants of the genus Anthocleista-A review of their 
ethnobotany, phytochemistry and pharmacology. J Etnopharmacol 175:648-667 
2. Awad AB and Fink CS (2000) Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr 130: 
2127-2130  
3. Bailey PJ and Sturm A (1983) Immune complexes and inflammation. A study of the activity of anti-inflammatory drugs in the 
reverse passive Arthus reaction in the rat. Biochem Pharmacol 32:475-481 
4. Bouic PJ (2002) Sterols and sterolins: new drugs for the immune system? Drug Discov Today 7: 775-778 
5. Choudhary SP and Trans LS (2011) Phytosterols: perspectives in human nutrition and clinical therapy. Curr Med Chem 
18:4557-4567 
6. Dwevedi A, Sharma K and Sharma YK (2015) Cadamba: A miraculus tree having enormous pharmacological implications. 
Pharmacogn Rev 9:107-113 
Peniagua-Pérez et al, Afr J Tradit Complement Altern Med., (2017) 14 (1): 123-130 
doi:10.21010/ajtcam.v14i1.13 
130 
 
7. Farkouh ME, Greenberg JD, Jeger RV, Ramanathan K, Verheugt FW, Chesebro JH,  Kishner H, Hochman JS, Lay CL, Ruland 
S, Mellein B, Matchaba PT, Fuster V and Abramson SB 2007. Cardiovascular outcomes in high risk patients with osteoarthritis 
treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis. 66: 764-770 
8. Fry DE (2012) Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. Am Surg 78: 1-
8 
9. Gaffo A, Saag KG and Curtis JR (2006) Treatment of rheumatoid arthritis. Am J Health Syst Pharm 63:2451-2465  
10. García-Martínez O, De Luna Bertos E, Ramos-Torrecillas J, Manzano-Moreno FJ and Ruiz C (2015) Repercussions of 
NSAIDS drugs on bone tissue: the osteoblast. Life Sci. 123:72-77   
11. Goldstein JL (2004) Challenges in managing NSAID-associated gastrointestinal tract injury. Digestion 69 Suppl 1:25-33 
12. Goldstein JL and Cryer B (2015) Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and 
preventative strategies. Drug Healthc Patient Saf. 7:31-41  
13. Gupta MB, Nath R, Shrivastava N, Shanker K, Kishor K and Bhargava KP (1980) Anti-inflammatory and antipyretic activities 
of beta-sitosterol. Planta Med 39:157-163 
14. Han NR, Kim HM and Jeong HJ (2014) The -sitosterol  attenuates atopic dermatitis-like skin lesions through down-regulation 
of TSLP. Exp Biol Med 239:454-464 
15. He C, Li W, Zhang JJ, Qu SS, Li JJ and Wang LY (2014) Determination of  -sitosterol  and total sterols content and 
antioxidant activity of oil in acai (Euterpe oleracea). Zhongguo Zhong Yao Za Zhi 39:4620-4624 
16. Heitzman ME, Neto CC, Winiarz E, Vaisberg AJ and Hammond GB (2005) Ethnobotany, phytochemistry and pharmacology of 
Uncaria (Rubiaceae). Phytochemistry 66:5-29 
17. Hewing B and Fisher EA (2012) Preclinical mouse models and methods for the discovery of the causes and treatments of 
atherosclerosis. Expert Opin Drug Discov 7:207-216 
18. Huang GJ, Deng JS, Huang SS, Wang SY, Chang YS and Kuo YH (2013) Bioassay guided isolation and identification of anti-
inflammatory active compound from the root of Ficus formosana. J Agric Food Chem 61:11008-11015  
19. Jamkhande PG, Barde SR, Patwekar SL and Tidke PS (2013) Plant profile, phytochemistry and pharmacology of Cordia 
dichotoma (Indian cherry): a review. Asian Pac J Trop Biomed 3:1009-1016 
20. Kalafutova S, Juraskova B and Vlcek J (2014) The impact of combinations of non-steroidal anti-inflammatory drugs and anti-
hypertensive agents on blood pressure. Adv Clin Exp Med 23:993-1000  
21. Ling WH and Jones PJ (1995) Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci. 57:195-206  
22. Liz R, Zanatta L, dos Reis GO, Horst H, Pizzolatti MG, Silva FR and Fröde TS (2013) Acute effect of  -sitosterol  on calcium 
uptake mediates anti-inflammatory effect in murine activated neutrophils. J Pharm Pharmacol 65:115-122   
23. Loizou S, Lekakis I, Chrousos  GP and Moutsatsou P (2010) Beta-sistosterol exhibits anti-inflammatory activity in human 
aortic endothelial cells. Mol Nutr Food Res 54:551-558  
24. Mahajan SG and Mehta AA (2011) Suppression of ovalbumin-induced Th2-driven airway inflammation by  -sitosterol  in a 
guinea pig model of asthma. Eur J Pharmacol 650:458-464 
25. McInnes IB and Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205-2219 
26. Medzhitov R (2010) Inflammation 2010: new adventures of an old flame. Cell 140:771-776 
27. Naressi MA, Ribeiro MA, Bersani-Amado CA, Zamuner ML, Costa WF, Tanaka CM and Sarragiotto MH (2012) Chemical 
composition, anti-inflammatory, molluscidal and free-radical scavenging activities of the leaves of Ficus radicans ´Variegata´ 
(Moraceae). Nat Prod Res 26:323-330 
28. Perez DA, Vago JP, Athaide RM, Reis AC, Teixeira MM, Sousa LP and Pinho V (2014) Switching off key signaling survival 
molecules to switch on the resolution of inflammation. Mediators Inflamm. 2014:829851    
29. Pflum LR and Graeme ML (1979) The Arthus reaction in rats, a possible test for anti-inflammatory and antirheumatic drugs. 
Agents Action 9:184-189 
30. Piscoya J, Rodriguez Z, Bustamante SA, Okuhama NN, Miller MJ and Sandoval M (2001) Efficacy and safety of freeze-dried 
cat´s claw in osteoarthritis of the knee: mechanism of action of the species Uncaria guianensis. Inflamm Res 50:442-448 
31. Saeidnia S, I A, Gohari AR and Abdollahi M (2014) The story of beta-sitosterol-A review. European J of Med Plants 4:590-609 
32. Serhan CN, Brain CD, Buckley CD, Gilroy DW, Haslett C, O´Neill LA, Perretti M, Rossi AG and Wallace JL (2007) 
Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:225-332  
33. Serhan CN and Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191-1197 
34. Susuki K, Ota H, Sasagawa S, Sakatani T and Fujikura T (1983) Assay method for myeloperoxidase in human 
polymorphonuclear leukocytes. Anal Biochem 132:345-352 
35. Susuki R, Kohno H, Sugie S and Tanaka T.  2005. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon 
carcinogenesis initiated with azoxymethane. Histol Histophathol 20:483-492 
36. Szalai AJ, Digerness SB, Agrawal A, Kearney JF, Bucy RP, Niwas S, Kilpatrick JM, Babu YS and Volanakis JE (2000) The 
Arthus reaction in rodents: species-specific requirement of complement. J Inmunol 164:463-468 
37. Tapiero H, Townsend DM and Tew KD (2003) Phytosterols in the prevention of human pathologies. Biomed Pharmacother 
57:321-325 
38. Tovey FI (2015) Role of dietary phospholipids and phytosterols in protection against peptic ulceration as shown by experiments 
on rats. World J Gastroenterol 21:1377-1384 
39. Uddin G, Rauf A, Siddiqui BS, Muhammad N, Khan A and Shah SU (2014) Anti-nociceptive, anti-inflammatory and sedative 
activities of the extracts and chemical constituents of Diospyros lotus L. Phytomedicine 21:954-959 
40. Wilt TJ, MacDonald R and Ishani A (1999) beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic 
review. BJU Int 83:976-983   
41. Young JM and De Joung LM (1989) Cutaneous models of inflammation for evaluation of topical and systemic pharmacological 
agents. In: Spector S,  Back N (eds) Modern methods in pharmacology. Pharmacological methods in the control of 
inflammation. Alan R. Liss, New York pp 215-231 
42. Yuk JE, Woo JS, Yun CY, Lee JS, Kim JH, Song GY, Yang EJ, Hur IK and Kim IS (2007) Effects of lactose-beta-sitosterol 
and beta-sitosterol on ovalbumin-induced lung inflammation in actively sensitized mice. Int Immunopharmacol 7:1517-1527. 
